Pulmonx to Report Fourth Quarter and Full Year 2022 Financial Results on February 22, 2023
February 08, 2023 16:05 ET
|
Pulmonx Corporation
REDWOOD CITY, Calif., Feb. 08, 2023 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for lung disease, today announced that it...
Pulmonx to Present at the 34th Annual Piper Sandler Healthcare Conference
November 16, 2022 16:05 ET
|
Pulmonx Corporation
REDWOOD CITY, Calif., Nov. 16, 2022 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for severe lung disease, today announced the...
Pulmonx to Participate at Upcoming Investor Conferences
November 04, 2022 08:00 ET
|
Pulmonx Corporation
REDWOOD CITY, Calif., Nov. 04, 2022 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for severe lung disease, today announced the...
Pulmonx Reports Third Quarter 2022 Financial Results
November 03, 2022 16:05 ET
|
Pulmonx Corporation
REDWOOD CITY, Calif., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today...
Pulmonx to Report Third Quarter 2022 Financial Results on November 3, 2022
October 20, 2022 16:05 ET
|
Pulmonx Corporation
REDWOOD CITY, Calif., Oct. 20, 2022 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for lung disease, today announced that it...
Pulmonx Reports Second Quarter 2022 Financial Results
August 02, 2022 16:05 ET
|
Pulmonx Corporation
REDWOOD CITY, Calif., Aug. 02, 2022 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today...
Pulmonx Reports First Quarter 2022 Financial Results
May 03, 2022 16:05 ET
|
Pulmonx Corporation
REDWOOD CITY, Calif., May 03, 2022 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today...
Pulmonx to Present at the Bank of America Securities 2022 Healthcare Conference
April 26, 2022 16:05 ET
|
Pulmonx Corporation
REDWOOD CITY, Calif., April 26, 2022 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”) a global leader in minimally invasive treatments for severe lung disease, today announced the...
Pulmonx to Report First Quarter 2022 Financial Results on May 3, 2022
April 19, 2022 16:05 ET
|
Pulmonx Corporation
REDWOOD CITY, Calif., April 19, 2022 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for lung disease, today announced that it...
Pulmonx Reports Fourth Quarter and Full Year 2021 Financial Results
February 23, 2022 16:05 ET
|
Pulmonx Corporation
REDWOOD CITY, Calif., Feb. 23, 2022 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today...